search
Back to results

Rutgers Pilot for PREDICT- Patient POC Test

Primary Purpose

SARS CoV 2 Infection

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Testing for SARS CoV2 Antigen
Sponsored by
Rutgers, The State University of New Jersey
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for SARS CoV 2 Infection focused on measuring Screening, Point-of-care testing, Asymptomatic patients, Perception of safety, Feasibility

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Dental Patients with upcoming appointment at the Oral Medicine Clinic at Rutgers School of Dental Medicine Exclusion Criteria: Patients previously participating in the study Patients unwilling to have their de-identified data made available to researchers

Sites / Locations

  • Rutgers School of Dental Medicine

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

SARS-CoV-2 testing

Arm Description

There is only one arm in this study- the study is a non-randomized pilot. All the subjects will be tested for SARS CoV 2 viral Antigen as described.

Outcomes

Primary Outcome Measures

Patient willingness to follow through with the study surveys, triage and testing
Percentage of patients who complete the study
Patient test completion
Percentage of patients with completed SARS-CoV-2 testing
Patient ease of complying with protocol
Questions on survey on how easy it was to complete pre-visit and post-visit formalities
Percentage of surveys completed by patients
Percentage of patients with completed pre-visit, triage and post-visit surveys completed

Secondary Outcome Measures

Full Information

First Posted
October 31, 2022
Last Updated
March 27, 2023
Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Institute of Dental and Craniofacial Research (NIDCR)
search

1. Study Identification

Unique Protocol Identification Number
NCT05612724
Brief Title
Rutgers Pilot for PREDICT- Patient POC Test
Official Title
Rutgers Pilot for Pragmatic Return to Effective Dental Infection Control Through Triage and Testing (PREDICT)- Patient POC Test
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
December 30, 2020 (Actual)
Primary Completion Date
October 31, 2022 (Actual)
Study Completion Date
October 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Institute of Dental and Craniofacial Research (NIDCR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral antigen using a point-of-care (POC) Rapid Antigen test. 14 subjects with upcoming appointment at the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated patients' perceptions of safety and feedback regarding their testing experience. All 14 patients expressed initial interest, however, 10 patients completed informed consent and completed study procedures. Institutional Clinical Laboratory Improvement Amendments (CLIA) certification of waiver was obtained prior to conducting the study. Communicable Diseases Reporting and Surveillance System (CDRSS) registration and training were completed to enable reporting results of the POC test.
Detailed Description
A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral antigen using a point-of-care (POC) Rapid Antigen test. 14 subjects with upcoming appointment at the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated patients' perceptions of safety and feedback regarding their testing experience. All 14 patients expressed initial interest, however, 10 patients completed informed consent and completed study procedures on their appointments, the remaining 4 patients did not present for their appointment. Following initial interest in participation over the phone, the subjects completed a pre-visit survey prior to their upcoming appointment. The day prior to their visit, a phone triage was completed and repeated as they checked in for their appointment. A nasal sample was collected and processed using the FDA EUA authorized Rapid Antigen Test BD Veritor Plus Analyzer, BD Sciences. An end-of-study survey was collected to assess patients' feedback about their experience and their perception of safety.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
SARS CoV 2 Infection
Keywords
Screening, Point-of-care testing, Asymptomatic patients, Perception of safety, Feasibility

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Pilot study to assess feasibility of testing asymptomatic dental patients for SARS-CoV-2 antigen using Rapid Antigen point-of-care testing
Masking
None (Open Label)
Allocation
N/A
Enrollment
14 (Actual)

8. Arms, Groups, and Interventions

Arm Title
SARS-CoV-2 testing
Arm Type
Other
Arm Description
There is only one arm in this study- the study is a non-randomized pilot. All the subjects will be tested for SARS CoV 2 viral Antigen as described.
Intervention Type
Device
Intervention Name(s)
Testing for SARS CoV2 Antigen
Intervention Description
Device: Testing for SARS CoV2 Antigen Antigen testing: Rapid Antigen testing (Point-of-care)
Primary Outcome Measure Information:
Title
Patient willingness to follow through with the study surveys, triage and testing
Description
Percentage of patients who complete the study
Time Frame
Day 1
Title
Patient test completion
Description
Percentage of patients with completed SARS-CoV-2 testing
Time Frame
Day 1
Title
Patient ease of complying with protocol
Description
Questions on survey on how easy it was to complete pre-visit and post-visit formalities
Time Frame
Day 1
Title
Percentage of surveys completed by patients
Description
Percentage of patients with completed pre-visit, triage and post-visit surveys completed
Time Frame
Through study completion (3 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Dental Patients with upcoming appointment at the Oral Medicine Clinic at Rutgers School of Dental Medicine Exclusion Criteria: Patients previously participating in the study Patients unwilling to have their de-identified data made available to researchers
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cecile A Feldman
Organizational Affiliation
Rutgers School of Dental Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rutgers School of Dental Medicine
City
Newark
State/Province
New Jersey
ZIP/Postal Code
07103
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
D: No If the COVID test results show that a participant is positive for COVID-19, the study staff will tell the participant the results. The study staff will be required to give the participant's name to the state's Department of Public Health if the participant tests positive because this is the law. At the end of the study, de-identified data will be provided to the National Coordinating Center.
Citations:
Citation
1. American Dental Association COVID-19 Toolkit - Update to Office Procedures During COVID-19. https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/resources/coronavirus/update_to_office_procedures_during_covid19.pdf accessed on November 11, 2021.
Results Reference
background
PubMed Identifier
33071007
Citation
Estrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, Araujo MWB. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020 Nov;151(11):815-824. doi: 10.1016/j.adaj.2020.09.005.
Results Reference
background
PubMed Identifier
34176567
Citation
Shirazi S, Stanford CM, Cooper LF. Testing for COVID-19 in dental offices: Mechanism of action, application, and interpretation of laboratory and point-of-care screening tests. J Am Dent Assoc. 2021 Jul;152(7):514-525.e8. doi: 10.1016/j.adaj.2021.04.019. Epub 2021 May 4. Erratum In: J Am Dent Assoc. 2021 Sep;152(9):719.
Results Reference
background

Learn more about this trial

Rutgers Pilot for PREDICT- Patient POC Test

We'll reach out to this number within 24 hrs